The involvement of σ receptors in the choice reaction performance deficits induced by phencyclidine

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 147-152

  Jin, Jingji ^a   Yamamoto, Tsuneyuki ^a   Watanabe, Shigenori ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Receptor; Attention; Choice reaction time; Phencyclidine

Indexed keywords

1 CYCLOPROPYLMETHYL 4 [2 (4 FLUOROPHENYL) 2 OXOETHYL]PIPERIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 4 [2 (4 CYANOPHENYL) 2 OXOETHYL] 1 (CYCLOPROPYLMETHYL)PIPERIDINE; DELTA OPIATE RECEPTOR; N ALLYLNORMETAZOCINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPONSE TIME;

ANIMALS; ANISOLES; ANTIPSYCHOTIC AGENTS; EXCITATORY AMINO ACID AGONISTS; LIGANDS; MALE; PHENAZOCINE; PHENCYCLIDINE; PIPERIDINES; PROPYLAMINES; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, SIGMA;

EID: 0031018736     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00858-8     Document Type: Article

References (21)

1. Bakker, C.B. and F.B. Amini, 1961, Observations on the psychotomimetic effects of sernyl, Compr. Psychiatry 2, 269.
2. Braff, D.L., C. Grillon and M.A. Geyer, 1992, Gating and habituation of the startle reflex in schizophrenic patients, Arch. Gen. Psychiatry 49, 206.
3. Chaki, S., M. Tanaka, M. Muramatsu and S. Otomo, 1994, NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain, Eur. J. Pharmacol. 251, R1.
4. Cohen, B.D., G. Rosenbaum, E.D. Luby and J.S. Gottlieb, 1961, Comparison of phencyclidine hydrochloride (Sernyl) with other drugs, Arch. Gen. Psychiatry 6, 79.
5. Erlenmeyer-Kimling, L., B.A. Cornblatt, D. Rock, S. Roberts, M. Bell and A. West, 1993, The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology, Schizophr. Bull. 19, 141.
6. Jones, S.H., D.R. Hemsley and J.A. Gray, 1991, Contextual effects on choice reaction time and accuracy in acute and chronic schizophrenics. Impairment in selective attention or in the influence of prior learning? Br. J. Psychiatry 159, 415.
7. Monnet, F.P., 1993, [Involvement of sigma receptors in schizophrenic syndromes. Pathophysiological approach], Presse. Med. 22, 218.
8. Ogawa, S., S. Okuyama, H. Araki and S. Otomo, 1994, Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction, Eur. J. Pharmacol. 263, 9.
9. Okuyama, S., Y. Imagawa, S. Ogawa, H. Araki, A. Ajima, M. Tanaka, M. Muramatsu, A. Nakazato, K. Yamaguchi, M. Yoshida and S. Omoto, 1993, NE-100, a novel sigma receptor ligand; in vivo tests, Life Sci. 53, PL285.
10. Okuyama, S., Y. Imagawa, T. Sakagawa, A. Nakazato, K. Yamaguchi, M. Katoh, S. Yamada, H. Araki, S. Otomo, 1994, NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeys, Life Sci. 55, PL133.
11. Posner, M.I. and S.E. Petersen, 1990, The attention system of the human brain, Annu. Rev. Neurosci. 13, 25.
12. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites: Trends Pharmacol. Sci. 13, 85.
13. Rosenbaum, G., B.D. Cohen, E.D. Luby, J.S. Gottlieb and D. Yelen, 1959, Comparisons of sernyl with other drugs, Arch. Gen. Psychiatry 1, 651.
14. Shibuya, H., H. Mori and M. Toru, 1992, Sigma receptors in schizophrenic cerebral cortices, Neurochem. Res. 17, 983.
15. Tam, S.W., G.F. Steinfels, P.J. Gilligan, J.F. McElroy, V.J. DeNoble, A.L. Johnson and L. Cook, 1991, DuP734 is a novel sigma receptor antagonist, Soc. Neurosci. Abstr. 17, 333.
16. Tam, S.W., G.F. Steinfels, P.J. Gilligan, W.K. Schmidt and L. Cook, 1992, Dup734 [1-(cyclopropylmethyl)-4-(2′-(4″-fluorophenyl)-2′-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine 2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles, J. Pharmacol. Exp. Ther. 263, 1167.
17. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, B. Decosta and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
18. Weissman, A.D., T.P. Su, J.C. Hedreen and E.D. London, 1988, Sigma receptors in post-mortem human brains, J. Pharmacol. Exp. Ther. 247, 29.
19. Weissman, A.D., M.F. Casanova, J.E. Kleinman, E.D. London and E.B. De-Souza, 1991, Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia, Biol. Psychiatry 29, 41.
20. 3H]-(+)-Pentazocine binding to sigma recognition sites in human cerebellum, Life Sci. 55, PL389.
21. Zhou, G.Z., A.G. Katki, S. Schwarz, P.J. Munson and D. Rodbard, 1991, Quantitative characterization of multiple binding sites for phencyclidine and N-allylnormetazocine in membranes from rat and guinea pig brain, Neuropharmacology 30, 775.